Endothelial dysfunction in streptozotocin-diabetic rats is not reversed by dietary probucol or simvastatin supplementation

Diabetologia

Volumn 41, Issue 2, 1998, Pages 157-164

  Palmer, A M ^a   Gopaul, N ^b   Dhir, S ^b   Thomas, C R ^a   Poston, L ^a   Tribe, R M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acetylcholine; Antioxidants; Diabetes mellitus; Isoprostanes; Lipids; Nitric oxide; Probucol; Resistance artery; Simvastatin; Vascular endothelium

Indexed keywords

ACETYLCHOLINE; ANTILIPEMIC AGENT; ANTIOXIDANT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; PROBUCOL; PROSTAGLANDIN F2 ALPHA DERIVATIVE; SIMVASTATIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

EID: 0031935559     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050884     Document Type: Article

References (40)

1. Cameron NE, Cotter MA (1992) Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 35: 1011-1019
2. Taylor PD, McCarthy AL, Thomas CR, Poston L (1992) Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric arteries of streptozotocin-induced diabetic rats. Br J Pharmacol 107: 393-399
3. Taylor PD, Graves JE, Poston L (1995) Selective impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated resistance arteries of the streptozotocin-induced diabetic rat. Clin Sci 88: 1-6
4. McNally PG, Watt PAC, Rimmer T et al. (1994) Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin Sci 87: 31-36
5. Johnstone MT, Creager SJ, Scales KM et al. (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88: 2510-2516
6. Poston L, Taylor PD (1995) Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci 88: 245-255
7. Tribe RM, Poston L (1996) Oxidative stress and lipids in diabetes: a role in endothelium vasodilator dysfunction? Vasc Med 1: 195-206
8. Wolff SP (1993) Diabetes mellitus and free radicals. Br Med Bull 49: 642-652
9. Liao JK, Shin WS, Lee WY, Clark SL (1995) Oxidised low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 270: 319-324
10. Morel DW, Chisolm GM (1989) Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 30: 1827-1834
11. 2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J Chromatogr B 667: 199-208
12. 2α levels are elevated in individuals with non-insulin dependent diabetes mellilus. FEBS Lett 368: 225-229
13. 2α in diabetic rats are reduced by vitamins E and C. VIII Biennial Meeting, International Society for Free Radical Researche:P02 (Abstract)
14. Kamata K, Sugiura M, Kojima S, Kasuya Y (1996) Restoration of endothelium-dependent relaxation in both hypercholesterolacmia and diabetes by chronic taurine. Eur J Pharmacol 303: 47-53
15. Kamata K, Sugiura M, Kojima S, Kasuya Y (1996) Preservation of endothelium-dependent relaxation in cholesterol-fed and streptozotocin-induced diabetic mice by the chronic administration of cholestyramine. Br J Pharmacol 118: 385-391
16. Mamo JCL, Elsegood CL, Umeda Y, Hirano T, Redgrave TG (1993) Effect of probucol on plasma clearance and organ uptake of chylomicrons and VLDLs in normal and diabetic rats. Arterioscler Thromb 13: 231-239
17. Maeda E, Yoshino G, Matsushita M et al. (1993) Effect of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on triglyceride kinetics in chronically streptozotocin-diabetic rats. Metabolism 42: 52-57
18. Yoshino G, Matsushita M, Maeda E et al. (1994) Effect of long-term administration of probucol on triglyceride turnover in rats. Coron Artery Dis 5: 67-2
19. Keaney JF, Xu A, Cunningham D et al. (1995) Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest 95: 2520-2529
20. Simon BC, Haudenschild CC, Cohen RA (1993) Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J Cardiovasc Pharmacol 21: 893-901
21. Goode GK, Heagerty AM (1995) In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation 91: 2898-2903
22. Stroes ESG, Koomans HA, de Bruin TWA, Rabelink TJ (1995) Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 346: 467-471
23. Palmer AM, Thomas CR, Gopaul N, Dhir S, Änggård EE. Poston L, Tribe RM (1998) Dietary antioxidant supplementation reduces lipid peroxidation but impairs vasuclar function in small mesenteric arteries of the streptozotocin-diabetic rat. Diabetologia 41: 148-156
24. Ebara T, Hirano T, Mamo JCL et al. (1994) Hyperlipidemia in streptozocin-diabetic hamsters as a model for human insulin-deficient diabetes: comparison to streptozocin-diabetic rats. Metabolism 43: 299-305
25. Nourooz-Zadeh J, Gopaul NK, Forster LA, Ferns GAA, Anggard EE (1994) Measurement of plasma probucol levels by high-performance liquid chromatography. J Chromatogr B 654: 55-60
26. Mulvany MJ, Halpern W (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41: 19-26
27. Tooke JE (1986) Microvascular haemodynamics in diabetes mellitus. Clin Sci 70: 119-125
28. Tribe RM, Thomas CR, Poston L (1998) Flow-induced dilatation in isolated resistance arteries from control and streptozotocin-diabetic rats. Diabetologia 41: 34-39
29. Tada H, Oida K, Kutsumi Y et al. (1992) Effects of probucol on impaired cardiac performance and lipid metabolism in streptozotocin-induced diabetic rats. J Cardiovasc Pharmacol 20: 179-186
30. Hennig B, Ramasamy S, Alvarado A et al. (1993) Selective disruption of endothelial barrier function in culture by pure fatty acids and fatty acids derived from animal and plant fats. J Nutr 123: 1208-1216
31. Crosby AJ, Wahle KW, Duthie GG (1996) Modulation of glutathione peroxidase activity in human vascular endothelial cells by fatty acids and the cytokine interleukin-1 beta. Biochim Biophys Acta 1303: 187-192
32. Watts GF, O'Brien SF, Silvester W, Millar JA (1996) Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Clin Sci 91: 567-573
33. Plane F, Jacobs M, McManus D, Bruckdorfer KR (1993) Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins. Atherosclerosis 103: 73-79
34. Treasure CB, Klein JL, Weintraub WS et al. (1995) Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332: 481-487
35. Anderson TJ, Meredith IT, Yeung AC et al. (1995) The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332: 488-493
36. O'Driscoll G, Green D, Taylor RR (1997) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95: 1126-1131
37. McDowell IFW, Brennan GM, McEneny J et al. (1994) The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans. Eur J Clin Invest 24: 759-765
38. Regnstrom J, Walldius G, Nilsson S et al. (1996) The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis. Atherosclerosis 125: 217-229
39. Kuzuya M, Kuzuya F (1993) Probucol as an antioxidant and antiatherogenic drug. Free Radic Biol Med 14: 67-77
40. 2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res 77: 335-341